SCHEMBL11761322

SCHEMBL11761322

COc1ccc(CC(=O)c2ccc(OC)c(OC)c2OC)cc1OC

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.79
▸ SMN1; SMN2 Q16637 3/20 0.79
▸ MAPK1 P28482 1/20 0.79
▸ HTT P42858 3/20 0.68
▸ GAA P10253 2/20 0.62
▸ NPSR1 Q6W5P4 1/20 0.62
▸ HSP90AA1 P07900 3/20 0.61
▸ HIF1A Q16665 1/20 0.61
▸ NPC1 O15118 2/20 0.58
▸ MEN1 O00255 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ HPGD P15428 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ PDE4D Q08499 3/20 0.56
▸ POLB P06746 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ RIN1 Q13671 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ LDHA P00338 1/20 0.49
▸ RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14628590 0.85 LMNA (0.76) LMNASMN1; SMN2MAPK1HTTGAA
SCHEMBL30511126 0.81 SMN1; SMN2 (0.74) LMNASMN1; SMN2MAPK1HTTGAA
SCHEMBL12233251 0.81 LMNA (0.74) LMNASMN1; SMN2MAPK1HTTGAA
SCHEMBL2538729 0.81 SMN1; SMN2 (1.00) LMNASMN1; SMN2MAPK1HTTGAA
SCHEMBL29236768 0.80 LMNA (0.68) LMNASMN1; SMN2MAPK1HTTGAA
SCHEMBL29689390 0.80 LMNA (0.68) LMNASMN1; SMN2MAPK1HTTGAA
SCHEMBL11812190 0.80 LMNA (0.68) LMNASMN1; SMN2MAPK1HTTGAA
SCHEMBL1039742 0.79 SMN1; SMN2 (0.70) LMNASMN1; SMN2MAPK1HTTGAA
SCHEMBL7821807 0.78 LMNA (0.79) LMNASMN1; SMN2MAPK1HTTGAA
SCHEMBL30040198 0.78 LMNA (0.79) LMNASMN1; SMN2MAPK1HTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4015017-A Certain biphenyl derivatives used to treat disorders caused by increased capillary permeability LABORATOIRES PHARMASCIENCE (FR) 1977-03-29 — — US disclosed
Send feedback